Quest Health Solutions readies to scale

CORAL SPRINGS, Fla. – Quest Health Solutions has grown its top-line revenue 25% in the year since it received an investment from Sumitomo Corp. and CEO Adam Nadler expects that growth to continue with a new financial commitment from the Tokyo-based investor and a new acquisition. 

Sumitomo entered the U.S. health care market in mid-2024, when it invested in Vast Medical Holdings, the parent company of Quest, a provider of continuous glucose monitors and diabetes supplies, and its sister companies Quest Health Remote Care and Quest Health RPM Services.  

“They trusted us as their first health care platform investment and I take that very seriously,” said Nadler. “Them taking on additional ownership of the company just validates that we're doing well, and our companies are moving in the right direction.” 

Sumitomo also recently announced it had acquired St. Paul, Minn.-based ActivStyle, a U.S. provider of home medical supplies for patients with chronic conditions.  

The ActivStyle acquisition, combined with Quest and its sister companies, allows for a large “crossover play” to provide a unified care continuum across multiple product categories and health conditions, says Nadler. 

“If you can put multiple products in a box to ship to the patient, but also wrap that within a service, that is where the real value is and that's where I think we set ourselves apart,” he said. “So yes, we can provide CGMs and we're looking to provide incontinence supplies as sister entities.” 

Part of the backbone of the model is also a tech infrastructure that allows Quest to free employees to devote more time to patient care and improve outcomes, Nadler says. That infrastructure includes CompliantRx, a company that Nadler co-founded and is CEO of that offers an AI-powered platform that automates medical record review. 

“We’re starting to see patients getting their A1c lowered through our program,” he said. “We really believe in that white glove service and hands-on education. They feel supported and are more likely to stay on therapy.” 

Looking ahead, Quest has plans to expand into the Asia Pacific market, in particular Japan and Malaysia, where Nadler says, home-based care is behind the U.S. market. 

“As we become more mature, we’re going to enter those markets and help build out the digital experience for patients over there,” he said. “This partnership (with Sumitomo) allows us to scale with whatever works, and we believe the future of this industry is home care.” 

• Related: Quest thinks globally